Summary - CLNN - NASDAQ - Weiss Ratings

E

Clene Inc. CLNN

$3.00 -$0.17-5.36% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$2.57 - $9.20

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Biotechnology Consumer Staples Health Care Household Products

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Clene (CLNN) Receives Buy Rating and $30 Target from JonesResearch CLNN Stock News

4/23/2025 - GuruFocus

Clene initiated with a Buy at JonesResearch

4/23/2025 - TipRanks Financial Blog

Clene initiated with bullish view at JonesResearch, here's why

4/23/2025 - The Fly

Nanotechnology Stocks To Follow Now - April 20th

4/22/2025 - MarketBeat

Best Nanotechnology Stocks To Keep An Eye On - April 19th

4/21/2025 - MarketBeat

Nanotechnology Stocks To Keep An Eye On - April 18th

4/20/2025 - MarketBeat

Clene Inc. (NASDAQ:CLNN) Sees Large Increase in Short Interest

4/20/2025 - Ticker Report

Promising Nanotechnology Stocks To Watch Now - April 16th

4/18/2025 - MarketBeat

Best Nanotechnology Stocks To Watch Now - April 15th

4/17/2025 - MarketBeat

Nanotechnology Stocks To Consider - April 14th

4/16/2025 - MarketBeat

Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

4/16/2025 - Globe Newswire

Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

4/15/2025 - Globe Newswire

Clene to Present at the Emerging Growth Conference CLNN Stock News

4/14/2025 - GuruFocus

Clene to Present at the Emerging Growth Conference

4/14/2025 - GuruFocus

Clene to Present at the Emerging Growth Conference

4/14/2025 - Globe Newswire

Nanotechnology Stocks To Watch Today - April 9th

4/11/2025 - MarketBeat

Best Nanotechnology Stocks To Follow Today - April 6th

4/8/2025 - MarketBeat

Clene announces evidence of remyelination, neuronal repair with CNM-Au8

4/8/2025 - The Fly

Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8 Treatment At the American Academy of Neurology Late-Breaking Science Session

4/8/2025 - Globe Newswire

Nanotechnology Stocks To Add to Your Watchlist - April 5th

4/7/2025 - MarketBeat

Best Nanotechnology Stocks To Keep An Eye On - April 4th

4/6/2025 - MarketBeat

Promising Nanotechnology Stocks To Keep An Eye On - April 3rd

4/5/2025 - MarketBeat

Nanotechnology Stocks Worth Watching - April 2nd

4/4/2025 - MarketBeat

Nanotechnology Stocks To Follow Today - April 1st

4/3/2025 - MarketBeat

Best Nanotechnology Stocks To Research - March 31st

4/1/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Monday, March 24, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Week of May 5 and 9 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Apr 01, 2025 - $2.57

52-week High

Jun 07, 2024 - $9.20

Valuation

Market Cap

$25.89M - Nano Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

801 676 9695

Address

6550 South Millrock Drive
Salt Lake City, UT 84121

Country

Year Founded

--

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug... more